Medicare Enrolled
Dr. Daryl Banta, M.D.
Critical Care Medicine · Pasadena, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Banta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Banta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Banta
Dr. Daryl Banta is a critical care medicine specialist in Pasadena, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Banta performed 2,443 Medicare services across 1,280 unique beneficiaries.
Between the years covered by Open Payments, Dr. Banta received a total of $7,906 from 40 pharmaceutical and/or device companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Banta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 12% volume in CA
$7,906 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,443
Medicare services
Top 12% in CA for critical care medicine
1,280
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~129 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
910 | $99 | $161 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
414 | $99 | $171 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
413 | $174 | $434 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
308 | $32 | $66 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
99 | $138 | $312 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $133 | $261 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
35 | $33 | $108 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
35 | $49 | $63 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
35 | $51 | $93 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
33 | $68 | $112 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $75 | $115 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
19 | $12 | $60 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
18 | $69 | $401 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
14 | $56 | $283 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
13 | $115 | $172 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
13 | $28 | $41 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
1.4% medium
97.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,906
Total received (2018-2024)
Avg $1,129/year across 7 years
Top 16% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
40
Companies
348
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,861 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$44 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$643
2023
$288
2022
$505
2021
$655
2020
$693
2019
$2,712
2018
$2,409
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Inari Medical, Inc.
$270
GlaxoSmithKline, LLC.
$143
Mallinckrodt Hospital Products Inc.
$140
United Therapeutics Corporation
$26
AstraZeneca Pharmaceuticals LP
$24
Mylan Specialty L.P.
$20
Optinose US, Inc.
$20
Top 3 companies account for 86.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$1,768
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,076
AstraZeneca Pharmaceuticals LP
$450
Philips Electronics North America Corporation
$402
PORTOLA PHARMACEUTICALS, INC.
$370
ADVANCED RESPIRATORY, INC
$344
Mylan Specialty L.P.
$300
Actelion Pharmaceuticals US, Inc.
$286
Inari Medical, Inc.
$270
Sunovion Pharmaceuticals Inc.
$257
Grifols USA, LLC
$242
Merck Sharp & Dohme Corporation
$201
Genentech USA, Inc.
$172
Bayer HealthCare Pharmaceuticals Inc.
$163
La Jolla Pharmaceutical Company
$154
Circassia Pharmaceuticals Inc
$144
Mallinckrodt Hospital Products Inc.
$140
Edwards Lifesciences Corporation
$117
Janssen Pharmaceuticals, Inc
$114
Insmed, Inc.
$95
Shionogi Inc
$87
Allergan Inc.
$85
Covidien LP
$83
Regeneron Healthcare Solutions, Inc.
$73
Alexion Pharmaceuticals, Inc.
$61
Electromed, Inc.
$49
E.R. Squibb & Sons, L.L.C.
$49
PFIZER INC.
$48
Veran Medical Technologies, Inc.
$45
Melinta Therapeutics, Inc.
$45
Teva Pharmaceuticals USA, Inc.
$37
Mallinckrodt Enterprises LLC
$33
United Therapeutics Corporation
$26
GENZYME CORPORATION
$23
Paratek Pharmaceuticals, Inc.
$21
Optinose US, Inc.
$20
Advanced Respiratory, Inc
$18
Theravance Biopharma, Inc.
$16
Otsuka America Pharmaceutical, Inc.
$16
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6
Top 3 companies account for 41.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BEVESPI AEROSPHERE · BEVYXXA · BOSENTAN · BREO · BROVANA · Baxdela · DUAKLIR PRESSAIR · DUPIXENT · Dymista · ELIQUIS · Edge · Edwards SAPIEN 3 Transcatheter Heart Valve · Esbriet · FASENRA · FLOWTRIEVER CATHETER · Fetroja · GIAPREZA · LONHALA MAGNAIR · LifeVest · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · Prolastin-C · Prolastin-C Liquid · QVAR · Respiratoriy Care Undiv · S · SAMSCA · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Soliris · Spin · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VitalCough System · Trilogy 100 · UPTRAVI · Utibron · VIBATIV · Vabomere · Wellcentive Undiv · XARELTO · Xhance · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage · superDimension
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
158
Per 100K population
1.6
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi
3.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Banta is a clinical cardiology specialist, with above-average Medicare volume (top 12% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Banta experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Banta performed 910 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Banta receive payments from pharmaceutical companies?
Yes. Dr. Banta received a total of $7,906 from 40 companies across 348 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Banta's costs compare to other critical care medicines in Pasadena?
Dr. Banta's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Banta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Pasadena
Browse critical care medicines in Pasadena ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology